Q1 FY22 Corporate Performance Overview: CARE Ratings
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
CARE Ratings Research Report
Corporate performance as represented by a sample of 3008 companies reveals that there was a sharp increase in net sales and net profits mainly due to the base effects.
Growth rates get moderated significantly when aggregates are compared over 2019.
A size wise analysis shows that the smaller companies with quarterly sales of less than Rs 10 crore each witnessed a decline in sales compared with 2020.
Further except for the size-group of above Rs 500 crore, all other segments witnessed lower sales in 2021 compared with 2019.
Around more than half the sample companies had not yet reached the sales level of 2019 in the first quarter.
Clearly there is a long distance to be travelled here.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.